相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy
Makoto Oketani et al.
HEPATOLOGY RESEARCH (2012)
Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis
Yu Xuan Koo et al.
ANNALS OF HEMATOLOGY (2011)
Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities
Fabrizio Marcucci et al.
BLOOD (2011)
Reactivation of Hepatitis B Virus After Rituximab-Containing Treatment in Patients With CD20-Positive B-Cell Lymphoma
Kosei Matsue et al.
CANCER (2010)
Prospective Analysis of Hepatitis B Virus Reactivation in Patients With Diffuse Large B-Cell Lymphoma After Rituximab Combination Chemotherapy
Nozomi Niitsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+ B-Cell Lymphoma in the Rituximab Era
Marita Ziepert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier
N. Fukushima et al.
ANNALS OF ONCOLOGY (2009)
Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab
Winnie Yeo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma
Ming-Huang Chen et al.
ANNALS OF HEMATOLOGY (2008)
The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma
Yi-Fu He et al.
ANNALS OF HEMATOLOGY (2008)
Systematic review: The effect of preventive lamivudine on hepatitis B reactivation during chemotherapy
Rohit Loomba et al.
ANNALS OF INTERNAL MEDICINE (2008)
Management of viral hepatitis in hematologic malignancies
Roberto J. Firpi et al.
BLOOD REVIEWS (2008)
Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients
Pin-Nan Cheng et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy
Clara Targhetta et al.
HAEMATOLOGICA (2008)
The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis
Soon-Thye Lim et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma:: A study by the groupe d'Etude des lymphomes de l'adulte
P Feugier et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy
S Takai et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences
D Ganem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
D Lavanchy
JOURNAL OF VIRAL HEPATITIS (2004)
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
MR Smith
ONCOGENE (2003)
Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent
U Lazdina et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.
F Suzan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance
KS Gutfreund et al.
JOURNAL OF HEPATOLOGY (2000)
分享论文
